Compound 1838
Identifiers
- Canonical SMILES:
CC1CCc2c(C1)sc1nc([nH]c(=O)c21)-c1ccc(O)cc1
- IUPAC name:
5-(4-hydroxyphenyl)-11-methyl-8-thia-4,6-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one
- InChi:
InChI=1S/C17H16N2O2S/c1-9-2-7-12-13(8-9)22-17-14(12)16(21)18-15(19-17)10-3-5-11(20)6-4-10/h3-6,9,20H,2,7-8H2,1H3,(H,18,19,21)
- InChiKey:
TZWSGFZJLUMAJN-UHFFFAOYSA-N
External links
![]() 136212224 |
![]() CHEMBL4066449 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 5.37 | breast cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 312.09 g/mol | |||
HBA | 4 | |||
HBD | 2 | |||
HBA + HBD | 6 | |||
AlogP | 4.14 | |||
TPSA | 61.69 | |||
RB | 1 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acs.jmedchem.7b00275 | 8f | BRD4 O60885 |
H4 P62805 |
Biochemical assay | alphascreen BRD4 | pIC50 (half maximal inhibitory concentration, -log10) | 5.37 | |
10.1021/acs.jmedchem.7b00275 | 8f | BRD4 O60885 |
H4 P62805 |
Cellular assay | Anti-proliferative MCF-7 | MCF7 mammary carcinoma cells | pIC50 (half maximal inhibitory concentration, -log10) | 4.91 |
10.1021/acs.jmedchem.7b00275 | 8f | BRD4 O60885 |
H4 P62805 |
Cellular assay | Anti-proliferative MDA-MB-231 | MDA-MB-231 breast | pIC50 (half maximal inhibitory concentration, -log10) | 4.64 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7978 | 5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE | DB08777 | |
0.6682 | 3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one | DB06889 | |
0.6462 | (5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide | DB07397 | |
0.4104 | Sufugolix | DB06494 | |
0.4103 | DDP-225 | DB05642 | |
0.3858 | Relugolix | DB11853 | |
0.3689 | T-62 | DB12919 | |
0.3648 | Sagopilone | DB12391 | |
0.3646 | Udenafil | DB06267 | |
0.3643 | 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE | DB08789 | |
0.3611 | Pelitrexol | DB12757 | |
0.3524 | 5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide | DB08729 | |
0.3495 | 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide | DB06969 | |
0.3487 | 2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE | DB06986 | |
0.3475 | N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide | DB07217 |